圣湘生物
(688289)
| 流通市值：86.36亿 | | | 总市值：86.36亿 |
| 流通股本：5.75亿 | | | 总股本：5.75亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,252,372,952.77 | 834,318,517.89 | 437,346,014.85 | 1,641,533,008.19 |
| 营业总成本 | 1,190,121,965.26 | 767,843,840.43 | 373,874,252.96 | 1,396,281,013.98 |
| 其他经营收益 | | | | |
| 营业利润 | 112,075,586.11 | 115,924,359.19 | 52,067,500.64 | 203,271,353.27 |
| 利润总额 | 88,282,150.72 | 95,892,812.33 | 51,115,050.72 | 175,083,963.55 |
| 净利润 | 77,650,710.01 | 81,309,407.96 | 41,791,587.9 | 153,924,782.58 |
| 每股收益 | | | | |
| 其他综合收益 | -6,765,641.52 | -4,939,415.42 | -1,865,099.45 | -8,298,918.92 |
| 综合收益总额 | 70,885,068.49 | 76,369,992.54 | 39,926,488.45 | 145,625,863.66 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 4,923,367,352.57 | 5,064,017,918.26 | 5,160,630,982.14 | 5,274,236,741.68 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,670,626,776.8 | 4,572,400,709.92 | 4,446,139,565.83 | 4,252,443,134.72 |
| 资产总计 | 9,593,994,129.37 | 9,636,418,628.18 | 9,606,770,547.97 | 9,526,679,876.4 |
| 流动负债: | | | | |
| 流动负债合计 | 1,083,860,084.82 | 1,084,593,290.13 | 1,210,638,624.74 | 1,206,016,603.91 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,448,955,195.34 | 1,477,333,902.45 | 1,166,620,915.86 | 1,130,565,486.93 |
| 负债合计 | 2,532,815,280.16 | 2,561,927,192.58 | 2,377,259,540.6 | 2,336,582,090.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,964,534,267.16 | 6,994,719,087.09 | 7,163,991,732.82 | 7,116,117,505.44 |
| 股东权益合计 | 7,061,178,849.21 | 7,074,491,435.6 | 7,229,511,007.37 | 7,190,097,785.56 |
| 负债和股东权益合计 | 9,593,994,129.37 | 9,636,418,628.18 | 9,606,770,547.97 | 9,526,679,876.4 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,377,456,641.01 | 904,626,855.31 | 432,778,063.34 | 1,902,175,993.21 |
| 经营活动现金流出小计 | 1,406,495,316.66 | 920,283,311.88 | 433,742,451.49 | 1,718,215,149.51 |
| 经营活动产生的现金流量净额 | -29,038,675.65 | -15,656,456.57 | -964,388.15 | 183,960,843.7 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 289,716,505.6 | 186,047,401.82 | 25,282,615.16 | 849,946,342.59 |
| 投资活动现金流出小计 | 779,813,144.2 | 625,911,320.63 | 272,150,764.9 | 2,136,140,051.04 |
| 投资活动产生的现金流量净额 | -490,096,638.6 | -439,863,918.81 | -246,868,149.74 | -1,286,193,708.45 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 556,321,593.78 | 519,575,911.55 | 77,128,870.15 | 1,118,393,717.31 |
| 筹资活动现金流出小计 | 392,066,270.82 | 324,736,392.74 | 36,037,921.71 | 744,016,301.94 |
| 筹资活动产生的现金流量净额 | 164,255,322.96 | 194,839,518.81 | 41,090,948.44 | 374,377,415.37 |
| 汇率变动对现金及现金等价物的影响 | -9,921,094.75 | -7,492,158.87 | -3,987,574.39 | -2,230,122.3 |
| 现金及现金等价物净增加额 | -364,801,086.04 | -268,173,015.44 | -210,729,163.84 | -730,085,571.68 |
| 期末现金及现金等价物余额 | 3,381,741,359.2 | 3,478,369,429.8 | 3,535,813,281.4 | 3,746,542,445.24 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -268,173,015.44 | - | -730,085,571.68 |
最新报告期：2026-10-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 喻胜锋,李虹达,王在存,贺菊颖 | 0.40 | 0.44 | 0.51 | 2026-10-03 |